Published in Malar J on February 21, 2007
Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar J (2009) 2.23
Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers. Malar J (2011) 1.77
The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence. Malar J (2008) 1.40
Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa. Malar J (2007) 0.95
A retrospective evaluation of the quality of malaria case management at twelve health facilities in four districts in Zambia. Asian Pac J Trop Biomed (2014) 0.93
Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugs. Am J Trop Med Hyg (2007) 0.92
Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework. Implement Sci (2012) 0.90
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. Malar J (2014) 0.89
Challenges Associated with Scaling up Artemisinin Combination Therapy in Sub-Saharan Africa A Review Article. Libyan J Med (2008) 0.87
Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea. Bull World Health Organ (2011) 0.84
Evaluation of recurrent parasitemia after artemether-lumefantrine treatment for uncomplicated malaria in children in western Kenya. Am J Trop Med Hyg (2010) 0.82
Malaria management-progress made and challenges still to face. Malar J (2009) 0.82
Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis. Parasitol Res (2013) 0.75
Household costs among patients hospitalized with malaria: evidence from a national survey in Malawi, 2012. Malar J (2017) 0.75
Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ (1999) 12.10
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother (1997) 7.36
The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg (2001) 5.22
Economic foundations of cost-effectiveness analysis. J Health Econ (1997) 3.33
Preventing antimalarial drug resistance through combinations. Drug Resist Updat (1998) 3.11
Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med (2006) 2.18
Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia. East Afr Med J (2005) 1.93
A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa. Am J Trop Med Hyg (2004) 1.91
Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health (2004) 1.89
Cost effectiveness analysis in health care: contraindications. BMJ (2002) 1.80
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. Trop Med Int Health (2004) 1.75
Public health impact of drug resistant Plasmodium falciparum malaria. Acta Trop (2005) 1.74
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malar J (2006) 1.50
Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. Malar J (2006) 1.49
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med (2011) 3.32
National malaria control and scaling up for impact: the Zambia experience through 2006. Am J Trop Med Hyg (2008) 3.05
Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health (2004) 1.61
Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia. Cost Eff Resour Alloc (2009) 1.60
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Human exposure to anopheline mosquitoes occurs primarily indoors, even for users of insecticide-treated nets in Luangwa Valley, South-east Zambia. Parasit Vectors (2012) 1.38
Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali. Cost Eff Resour Alloc (2009) 1.23
Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management. Malar J (2011) 1.21
Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia. Trop Med Int Health (2005) 1.14
Documenting malaria case management coverage in Zambia: a systems effectiveness approach. Malar J (2013) 1.03
From targeted exemptions to user fee abolition in health care: experience from rural Zambia. Soc Sci Med (2010) 0.95
Association between early childhood exposure to malaria and children's pre-school development: evidence from the Zambia early childhood development project. Malar J (2013) 0.92
Assessing the impact of scaling-up bednet coverage through agricultural loan programmes: evidence from a cluster randomised controlled trial in Katete, Zambia. Trans R Soc Trop Med Hyg (2012) 0.90
Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission. AIDS (2016) 0.75
Impact of HIV/AIDS on Gross Domestic Product (GDP) in the WHO Africa Region. Afr J Health Sci (2007) 0.75
Costs along the HTC and PMTCT service cascades: findings from Kenya, Rwanda, South Africa, and Zambia. AIDS (2016) 0.75